{"id":16084,"date":"2013-01-10T10:30:00","date_gmt":"2013-01-10T09:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/lantitrust-risponde-a-federaisf-sullobbligo-di-prescrizione-dei-farmaci-equivalenti\/"},"modified":"2013-01-10T10:30:00","modified_gmt":"2013-01-10T09:30:00","slug":"lantitrust-risponde-a-federaisf-sullobbligo-di-prescrizione-dei-farmaci-equivalenti","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/lantitrust-risponde-a-federaisf-sullobbligo-di-prescrizione-dei-farmaci-equivalenti\/","title":{"rendered":"The ANTITRUST responds to FEDERAISF on the OBLIGATION to prescribe EQUIVALENT DRUGS"},"content":{"rendered":"<p><strong><span style=\"font-size: x-large\"><span style=\"font-family: Verdana\">This is the text of the registered letter received from the ANTITRUST:<\/span><\/span><\/strong><\/p>\n<p style=\"text-align: left\"><span style=\"font-size: medium\">Dear FEDERAISF<\/span><br \/> <span style=\"font-size: medium\">Federation of drug sales representatives&#039; associations<\/span><\/p>\n<p style=\"text-align: left\"><span style=\"font-size: medium\">REF.N. DC7732\/Q<\/p>\n<p> We inform you that in the meeting of 19\/12 the authority examined the report in question.<\/p>\n<p> On that occasion, the Authority assessed the facts reported by you and their possible significant implications from the point of view of the protection of competition and found that these facts fall outside the scope of its competences, not integrating any hypothesis of unlawful competition envisaged by national and Community antitrust regulations.<\/p>\n<p> The Authority thanks you for the attention shown to your institutional activity and takes the opportunity to send you cordial greetings.<\/p>\n<p> THE SECRETARY GENERAL <\/span><br \/> <span style=\"font-size: medium\"><br \/> <strong>Robert Chieppa.<\/strong><\/p>\n<p> registered letter 0066614 of 12\/27\/12<\/span><\/p>\n<p> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<\/p>\n<p><span style=\"font-size: medium\"><span style=\"font-family: Verdana\"><strong><span style=\"font-size: x-large\"><span style=\"font-family: Verdana\">This is the text of the report sent to the ANTITRUST by FEDERAISF on October 31st:<\/span><\/span><\/strong><\/span><\/span><\/p>\n<p><img","protected":false},"excerpt":{"rendered":"<p>Questo il testo della raccomandata ricevuta dall&#8217;ANTITRUST: Spett.le FEDERAISF Federazione delle associazioni di informatori scientifici del farmaco RIF.N. DC7732\/Q Si comunica, che nell&#8217;adunanza del 19\/12 l&#8217;utorit&agrave; ha esaminato la segnalazione in oggetto. In tale occasione l&#8217;Autorit&agrave; ha valutato i fatti da lei denunciati e&nbsp; le loro possibili implicazioni rilevanti dal punto di vista della tutela &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-16084","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=16084"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16084\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=16084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=16084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=16084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}